PL379145A1 - Compositions comprising gastrin compounds and their use in diabetes - Google Patents

Compositions comprising gastrin compounds and their use in diabetes

Info

Publication number
PL379145A1
PL379145A1 PL379145A PL37914504A PL379145A1 PL 379145 A1 PL379145 A1 PL 379145A1 PL 379145 A PL379145 A PL 379145A PL 37914504 A PL37914504 A PL 37914504A PL 379145 A1 PL379145 A1 PL 379145A1
Authority
PL
Poland
Prior art keywords
diabetes
compositions
gastrin compounds
gastrin
compounds
Prior art date
Application number
PL379145A
Other languages
Polish (pl)
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals, Inc. filed Critical Waratah Pharmaceuticals, Inc.
Publication of PL379145A1 publication Critical patent/PL379145A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2207Gastrins; Cholecystokinins [CCK]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
PL379145A 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes PL379145A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes

Publications (1)

Publication Number Publication Date
PL379145A1 true PL379145A1 (en) 2006-07-24

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
PL379145A PL379145A1 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Country Status (11)

Country Link
EP (1) EP1648495A2 (en)
JP (1) JP2007513059A (en)
CN (1) CN1829528A (en)
AU (1) AU2004243541A1 (en)
BR (1) BRPI0410710A (en)
CA (1) CA2527186A1 (en)
MX (1) MXPA05012605A (en)
NO (1) NO20055582L (en)
PL (1) PL379145A1 (en)
RU (1) RU2005140518A (en)
WO (1) WO2004105780A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156828A0 (en) 2001-01-12 2004-02-08 Waratah Pharmaceuticals Inc Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes
DE60329724D1 (en) 2002-06-07 2009-11-26 Waratah Pharmaceuticals Inc Methods and compositions to treat diabetes
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
US20090202494A1 (en) * 2004-01-30 2009-08-13 Antonio Cruz Combined use of glp-1 agonists and gastrin for regulating blood glucose levels
WO2008106779A1 (en) * 2007-03-02 2008-09-12 Waratah Pharmaceuticals Inc. Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
EP1842552A1 (en) * 1994-01-24 2007-10-10 The General Hospital Corporation Treatment for diabetes
IL156828A0 (en) * 2001-01-12 2004-02-08 Waratah Pharmaceuticals Inc Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes
US20040209801A1 (en) * 2002-10-22 2004-10-21 Brand Stephen J. Treatment of diabetes

Also Published As

Publication number Publication date
AU2004243541A1 (en) 2004-12-09
WO2004105780A2 (en) 2004-12-09
BRPI0410710A (en) 2006-06-13
RU2005140518A (en) 2007-07-10
CN1829528A (en) 2006-09-06
NO20055582L (en) 2006-02-27
CA2527186A1 (en) 2004-12-09
MXPA05012605A (en) 2006-02-22
JP2007513059A (en) 2007-05-24
EP1648495A2 (en) 2006-04-26
WO2004105780A3 (en) 2005-01-20
NO20055582D0 (en) 2005-11-25

Similar Documents

Publication Publication Date Title
IL171902A0 (en) Compositions comprising gastrin compounds and their use in diabetes
EP1679348A4 (en) Paste composition and use thereof
PL379145A1 (en) Compositions comprising gastrin compounds and their use in diabetes
GB0300804D0 (en) Compounds and their use
GB0300805D0 (en) Compounds and their use
GB0301143D0 (en) Compounds and their use
GB0317133D0 (en) Compounds and their use
GB0311164D0 (en) Composition and use
GB0325238D0 (en) Composition and use
GB0325239D0 (en) Composition and use
GB0325241D0 (en) Composition and use
GB0325237D0 (en) Composition and use
GB0311167D0 (en) Composition and use
GB0311166D0 (en) Composition and use
GB0311163D0 (en) Composition and use
GB0301401D0 (en) Composition and use
GB0314293D0 (en) Compounds and their use
GB0317281D0 (en) Compounds and their use
GB0301146D0 (en) Compounds and their use
GB0311820D0 (en) Compounds and their use
GB0311821D0 (en) Compounds and their use
GB0310470D0 (en) Compounds and their use
GB0314291D0 (en) Compounds and their use
GB0314292D0 (en) Compounds and their use
GB0316112D0 (en) Compounds and their use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)